Get started
Author

Vera Georgieva Megdanova

Observed names: V G Megdanova, V. Megdanova, Vera G. Megdanova-Chipeva, Vera Megdanova
ORCID: 0000-0003-4691-4070
Observed ORCID: 0000-0003-4691-4070
OpenAlex ID: A5039325468
Cholangiocarcinoma 2026: status quo, unmet needs and priorities
2025 · Jesus M. Banales, Pedro M. Rodrigues, et al. · Nature Reviews Gastroenterology & Hepatology · 123
PDF
Comparing Clinical Characteristics and Outcomes of Young-onset and Late-onset Colorectal Cancer: An International Collaborative Study
2017 · Young Soo Rho, Marine Gilabert, et al. · Clinical Colorectal Cancer · 75
Sarcopenia and high NLR are associated with the development of hyperprogressive disease after second-line pembrolizumab in patients with non-small-cell lung cancer
2020 · M P Petrova, I S Donev, et al. · Clinical & Experimental Immunology · 39
PDF
Systemic Treatment Selection for Patients with Advanced Pancreatic Neuroendocrine Tumours (PanNETs)
2020 · Vera G. Megdanova-Chipeva, Angela Lamarca, et al. · Cancers · 24
PDF
Lung cancer in Bulgaria ‒ diagnosis, treatment, and factors affecting survival: Bulgarian Single Institution experience in lung cancer treatment
2015 · Zhasmina Mihaylova, Vera Megdanova, et al. · memo - Magazine of European Medical Oncology · 3
Clinical outcomes of adolescent and young adults (AYA) with colorectal cancer (CRC), a multi-institutional retrospective review (MIRR).
2015 · Young soo Rho, Marine Gilabert, et al. · Journal of Clinical Oncology · 1
Limb-Sparing Resection with Prophylactic Tibial Fixation and Medial Gastrocnemius Flap Reconstruction for Recurrent Leiomyosarcoma in a Previously Irradiated Leg: A Case Report
2026 · Georgi P. Luchev, Lyubomir Gaydarski, et al. · Reports — Medical Cases Images and Videos
Clinical presentation and outcomes of sporadic neuroendocrine neoplasms in young adults
2026 · Anna Malczewska-Herman, Anja Rinke, et al. · European Journal of Endocrinology
1318P Neutrophil extracellular traps as a potential predictive marker for treatment with pembrolizumab alone or with chemotherapy as a first-line in patients with metastatic non-small cell lung cancer
2021 · M. Petrova, D. Parvanov, et al. · Annals of Oncology
Sarcopenia and high NLR are associated with the development of hyperprogressive disease after second-line pembrolizumab in patients with non-small-cell lung cancer
2020 · Ivan Donev, Mila Petrova, et al.
PDF
338. Comparing characteristics and survival outcomes of adolescent and young adults to mature patients with colorectal cancer
2016 · Y.S. Rho, M. Gilabert, et al. · European Journal of Surgical Oncology
2354 Is pancreatic adenocarcinoma more aggressive in adolescents and young adults? A multi-institute retrospective study
2015 · M. Gilabert, Y.S. Rho, et al. · European Journal of Cancer
2054 Clinical outcomes of adolescent and young adult patients (AYAp) vs mature adult patients (MATp) with colorectal cancer (CRC), a multi-institutional retrospective review
2015 · Y.S. Rho, M. Gilabert, et al. · European Journal of Cancer
P-286 Clinical and laboratory factors in young colorectal cancer patients with liver-only disease treated with upfront CAPOX and Bevacizumab combination – Single institution experience
2015 · V. Petrova, Z. Mihaylova, et al. · Annals of Oncology
PDF
Pancreatic neuroendocrine tumors (pNET) in adolescent and young adult (AYA) population: A multi-institutional study of characteristics and outcomes.
2015 · Marine Gilabert, Young soo Rho, et al. · Journal of Clinical Oncology
Continuum of care in advanced non-small lung cancer patients (ANSCLC).
2015 · Zhasmina Mihaylova, Vera Georgieva Megdanova, et al. · Journal of Clinical Oncology
Works count: 16
Citation count: 265
H-index: 4
I10-index: 4
Year
Topic
Type